UFPT News & Events

Reports Q1 revenue $154.2M, consensus $154.78M. "I am pleased with our first quarter results and continued progress with our strategic initiatives," said Jeffrey Bailly, Chairman and CEO. "Revenue grew 4.1%, driven by a 5.9% increase in our medical sales. This was offset by a 15% decline in our non-medical sales as we continue to focus our efforts on high-growth opportunities in the MedTech space. Our robotic surgery, patient surfaces and support, and interventional and surgical segments showed the strongest growth at 7%, 11%, and 15%, respectively. To increase capacity to meet strong forecasted demand, in Q2 we will take possession of two new facilities in the Dominican Republic - one in La Romana to support continued growth in our robotic surgery business, and one in Santiago to support growth and additional program transfers in the safe patient handling space."

Other 3-5 year financial targets include 28%-31% gross margin and 17%-20% operating margin. Comments taken from investor presentation slides.

Reports Q4 revenue $148.915M, consensus $149.07M. "I am pleased with our 2025 results and our progress on a number of key strategic initiatives," said R. Jeffrey Bailly, CEO. "Sales for the year grew 19.5% to $602.8 million, operating income grew 14.1% to $92.3 million, and EPS grew 15.4% to $8.75. Our growth was driven by a 23.2% increase in medical sales, partially offset by an 11.5% decrease in non-medical sales."

UFP Technologies announced that R. Jeffrey Bailly will retire as CEO at the Company's next annual meeting on June 4, 2026. At that time, Mitchell Rock, President of the Company, will assume the CEO position and join the Company's Board. To facilitate a smooth transition, Bailly will serve as Executive Chairman of the Board for the following year.